Are changes in NT-proBNP levels associated with the risk of CV death or HF hospitalization in patients with heart failure with preserved ejection fraction?
Monitoring changes in NT-proBNP levels may be a useful prognostic marker in patients with heart failure with preserved ejection fraction.
In HF-PEF, a rise in NT-proBNP was associated with an increase in risk of CV death or HF hospitalization and a fall was associated with a trend towards a decrease in risk. NT-proBNP may be a useful marker to monitor prognosis in this condition.
Jhund et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: